COPENHAGEN, Denmark, Nov. 12 /PRNewswire/ -- Gastrotech Pharma A/S announces today the appointment of Dr. Claes Post to the position of Chief Executive Officer of Gastrotech Pharma A/S. Dr. Post has an outstanding career, with strong industrial and academic background, currently as adjunct Professor of Neuropharmacology at Karolinska Institute, Stockholm, Sweden.
Dr. Post's industrial background stems from his time as Vice President Preclinical Pain and Inflammation Research at Astra Zeneca, Vice President of Urology Development and Vice President CNS at Pharmacia. Biotech Leadership was demonstrated as startup CEO of Melacure Therapeutics AB, a Drug Discovery company located to Uppsala, Sweden. During 2002 - 2003, he was partner at Danske Life Science, a venture capital fund within the Danske Bank.
Prof. Dr. Olle Isaksson, Chairman of the Board of Directors of Gastrotech Pharma says: "The addition of Dr. Post to Gastrotech Pharma A/S signals a new phase of the company's development with the expected initiation of multiple clinical trials in endocrinology indications." Professor Isaksson is Chairman at the Department of Internal Medicine, Sahlgrenska University Hospital in Gothenburg, Sweden and a leading authority in GH, IGF-1 and growth biology. He is also Member of the Board of Director of a number of companies, among them Tercica Medica Inc.
Dr. Claes Post remarks: "I am very happy to be leading the efforts in developing and commercializing the lead hormone pharmaceuticals of Gastrotech Pharma A/S addressing a significant market opportunity."
Florian Schonharting, Partner of Nordic Biotech K/S and lead investor in the series A financing round says: "We are very pleased to be able to attract the calibre of Dr. Claes Post to run the company. We see Gastrotech Pharma A/S going strongly forward and establishing a leading position in the endocrine pharmaceutical area."
About Gastrotech Pharma A/S
Gastrotech Pharma A/S is a newly founded company focusing on medical application of gastrointestinal hormones. The company is founded on the basis of research carried out at the medical faculty of Gothenburg University. The scientists are world leading experts in the field of endocrinology, and they have made ground breaking contributions in preclinical and clinical studies. Professor John-Olov Jansson, Professor Olle Isaksson and co-workers are among the founders. Gastrotech Pharma A/S aims to develop the pharmaceutical products to clinical evaluation in several disease areas of large unmet medical needs, where Gastrotech Pharma A/S expects significant improvements of the patient's quality of life. For more information visit http://www.gastrotechpharma.com/ .
About Nordic Biotech K/S
Nordic Biotech K/S is a Copenhagen based biotechnology venture fund focusing on investment in the Nordic area and the rest of EU. The investors of Nordic Biotech K/S are leading European and US institutions. For more information visit http://www.nordicbiotech.com/ .
Gastrotech Pharma A/SCONTACT: Claes Post, +45-33186144, or +45-26807475, for GastrotechPharma A/S; or Florian Schonharting, +45-27293200, for Nordic Biotech
